Releases

Media coverage

Newsletter

Subscribe to our newsletter

Archive


Jun 10, 2014

Lytix Biopharma has developed its antimicrobial technology further and patent protected a unique principle where effector molecules can be linked to different surfaces. This implies that many different products can be made self-sterilizing. Today, formulations of silver, copper and other heavy metals are used for this purpose. There is a clear need for more environmental friendly and custom made solutions, which is what Lytix Biopharma`s technology represent.

Read the press release